Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Montalbán

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Expert Review of Neurotherapeutics|April 1, 2011
New insights in the pathophysiology and treatment of multiple sclerosis spasticity and related symptoms. ForewordXavier Montalbán
Medicina Clinica|March 4, 2015
[Current description of multiple sclerosis]Jordi Río, Xavier Montalbán
Medicina Clinica|October 12, 2005
[Pachymeningitis as a first manifestation of an overlap vasculitic syndrome]Carmen Tur, Jordi Río, Alex Rovira, et al.
Frontiers in Cellular Neuroscience|June 4, 2026
Cellular senescence in brain aging and neurodegeneration: from molecular mechanisms to translational opportunitiesYahveth Cantero-Fortiz, Christopher Butler, Xavier Montalbán, et al.
Medicina Clinica|February 17, 2005
[Long-term effect of neutralizing antibodies to interferon beta-1 b in patients with multiple sclerosis]Jordi Río, Mar Tintoré, Nieves Téllez, et al.
Journal of Neurology|May 10, 2024
Long-term clinical outcomes in patients with CIS treated with interferon beta-1b: results from the 15-year follow up of the BENEFIT trialLudwig Kappos, Gilles Edan, Mark S Freedman, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 14, 2014
Evaluating the response to glatiramer acetate in relapsing-remitting multiple sclerosis (RRMS) patientsJordi Río, Alex Rovira, Mar Tintoré, et al.
Therapeutic Advances in Neurological Disorders|July 19, 2023
Clinical use of dimethyl fumarate in multiple sclerosis treatment: an update to include China, using a modified Delphi methodRalf Gold, Michael Barnett, Andrew Chan, et al.
Journal of Medical Genetics|April 22, 2014
HLA alleles as biomarkers of high-titre neutralising antibodies to interferon-β therapy in multiple sclerosisConcepción Núñez, M Carmen Cénit, Roberto Alvarez-Lafuente, et al.
Annals of Neurology|May 31, 2017
Sodium intake and multiple sclerosis activity and progression in BENEFITKathryn C Fitzgerald, Kassandra L Munger, Hans-Peter Hartung, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Expert Review of Neurotherapeutics|April 1, 2011
New insights in the pathophysiology and treatment of multiple sclerosis spasticity and related symptoms. ForewordXavier Montalbán
Medicina Clinica|March 4, 2015
[Current description of multiple sclerosis]Jordi Río, Xavier Montalbán
Medicina Clinica|October 12, 2005
[Pachymeningitis as a first manifestation of an overlap vasculitic syndrome]Carmen Tur, Jordi Río, Alex Rovira, et al.
Frontiers in Cellular Neuroscience|June 4, 2026
Cellular senescence in brain aging and neurodegeneration: from molecular mechanisms to translational opportunitiesYahveth Cantero-Fortiz, Christopher Butler, Xavier Montalbán, et al.
Medicina Clinica|February 17, 2005
[Long-term effect of neutralizing antibodies to interferon beta-1 b in patients with multiple sclerosis]Jordi Río, Mar Tintoré, Nieves Téllez, et al.
Journal of Neurology|May 10, 2024
Long-term clinical outcomes in patients with CIS treated with interferon beta-1b: results from the 15-year follow up of the BENEFIT trialLudwig Kappos, Gilles Edan, Mark S Freedman, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 14, 2014
Evaluating the response to glatiramer acetate in relapsing-remitting multiple sclerosis (RRMS) patientsJordi Río, Alex Rovira, Mar Tintoré, et al.
Therapeutic Advances in Neurological Disorders|July 19, 2023
Clinical use of dimethyl fumarate in multiple sclerosis treatment: an update to include China, using a modified Delphi methodRalf Gold, Michael Barnett, Andrew Chan, et al.
Journal of Medical Genetics|April 22, 2014
HLA alleles as biomarkers of high-titre neutralising antibodies to interferon-β therapy in multiple sclerosisConcepción Núñez, M Carmen Cénit, Roberto Alvarez-Lafuente, et al.
Annals of Neurology|May 31, 2017
Sodium intake and multiple sclerosis activity and progression in BENEFITKathryn C Fitzgerald, Kassandra L Munger, Hans-Peter Hartung, et al.
Pageof 5